At first sight, ‘Right-to-Try’ legislation seems to promise unconstrained access to experimental drugs. But is this really the case? For a reflection on the distance between ‘law-in-books’ and ‘law-in-action’ check this brief contribution by Martani, Tomasi and Casonato